Related Experiment Video
Updated: Aug 11, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Role for GLUT1 in diabetic glomerulosclerosis
Charles W Heilig1, Frank C Brosius, Carol Cunningham
1Department of Medicine, University of Chicago Hospitals, Chicago, IL, USA. cheilig@medicine.bsd.uchicago.edu
Abstract:
Numerous studies have investigated specific pathways that link diabetes and high extracellular glucose exposure to glomerulosclerosis and mesangial cell extracellular matrix production. However, only in the past ten years has a role for glucose transporters in this process been addressed. Many different glucose transporters are expressed in glomeruli; of these, the GLUT1 facilitative glucose transporter is upregulated in the diabetic renal cortex and in response to glomerular hypertension, as well as in cultured mesangial cells exposed to high glucose. Transgenic mouse and cell models have recently been developed to test the role of GLUT1 in the pathogenesis of glomerulosclerosis with and without diabetes. Clinical studies of GLUT1 alleles performed in humans have identified GLUT1 susceptibility alleles for diabetic nephropathy. Studies are also currently under way to assess the potential role of GLUT1 in nondiabetic renal disorders.
Related Concept Videos
Diabetic Nephropathy
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Type I Diabetes I: Introduction
Oral Hypoglycemic Agents: Biguanides and Glitazones
